ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $381 | -99.9% | 18,721 | +28.4% | 0.04% | -5.0% |
| Q3 2021 | $395,000 | +34.4% | 14,583 | +6.7% | 0.04% | -16.7% |
| Q4 2020 | $294,000 | -23.2% | 13,664 | -47.3% | 0.05% | -25.0% |
| Q3 2020 | $383,000 | +122.7% | 25,934 | +113.0% | 0.06% | +48.8% |
| Q1 2020 | $172,000 | -78.0% | 12,178 | -74.7% | 0.04% | -52.7% |
| Q4 2019 | $782,000 | +71.5% | 48,112 | +269.1% | 0.09% | +46.8% |
| Q3 2019 | $456,000 | – | 13,034 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |